Acrobiosystems Co.,Ltd. engages in the development and manufacture of recombinant proteins, antibodies, and other biological reagents for pharmaceutical and biotechnology companies, and scientific research institutions. The company has a collaboration with Diagnostic Biochips Inc for neurological drug discovery and commercialization. The company was founded in 2010 and is based in Beijing, China.
Stock data | 2024 | Change |
---|---|---|
Price | $4.47 | N/A |
Market Cap | $536.22M | N/A |
Shares Outstanding | 120.00M | N/A |
Employees | 597.00 | N/A |